The serodiagnosis of infections caused by Verocytotoxin-producing Escherichia coli.
Patients with haemolytic uraemic syndrome (HUS) and haemorrhagic colitis (HC) produce serum antibodies to the lipopolysaccharides (LPS) of Escherichia coli O157 and certain other E. coli serogroups. Patients may also make salivary antibodies to the LPS of E. coli O157. Serological tests based on these antibodies can be used to provide evidence of infection in the absence of culturable VTEC or the toxins they produce. Serum antibodies to LPS persist for several months following onset of disease, enabling both current and retrospective serological testing. The LPS of E. coli O157 shares epitopes with strains of Brucella abortus, Yersinia enterocolitica O9, Vibrio cholerae O1 Inaba, group N Salmonella and certain strains of Citrobacter freundii and E. hermanni. Serological tests for serum antibodies to E. coli O157 should be evaluated in the light of these cross-reactions. Serological tests to supply evidence of infection with E. coli O157 have been shown to provide a valuable adjunct to bacteriological procedures for detecting culturable VTEC and VT. The use of well characterized LPS antigens in association with the techniques of ELISA and immunoblotting provide valuable procedures for detecting evidence of infection with E. coli O157 and possibly other VTEC.
Chart
H
H
Laboratory of Enteric Pathogens, Central Public Health Laboratory, London, UK.
Jenkins
C
C
D000907:Antibodies, Bacterial / Q000097:blood; D001427:Bacterial Toxins; D003092:Colitis / Q000097:blood; D003603:Cytotoxins; D004927:Escherichia coli Infections / Q000097:blood*; D019453:Escherichia coli O157 / Q000276:immunology*; D006463:Hemolytic-Uremic Syndrome / Q000097:blood; D006801:Humans; D008070:Lipopolysaccharides / Q000276:immunology; D012698:Serologic Tests / Q000379:methods*; D022622:Shiga Toxin 1
D000907:Antibodies, Bacterial; D001427:Bacterial Toxins; D003603:Cytotoxins; D008070:Lipopolysaccharides; D022622:Shiga Toxin 1